NGMD — NuGen Medical Devices Share Price
0.000.00%
Last trade - 00:00- CA$22.41m
- CA$28.19m
- CA$0.15m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 121.32 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -134.62% | ||
| Return on Equity | n/a | ||
| Operating Margin | -3901.36% | ||
Financial Summary
| Year End 31st Dec | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | 0.14 | 0.15 | n/a | n/a | 10.69% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
NuGen Medical Devices Inc. is a Canada-based specialty medical device company. The Company is engaged in marketing and selling its InsuJet needle-free injection system designed to improve the lives of millions of diabetics. Its principal business is the research, development and commercialization of needle-free injection devices and systems for the administration of subcutaneous medication. It is developing products using its needle-free delivery technology in several fields including, but not limited to, diabetes, semaglutide, growth and fertility hormone, as well as deoxyribonucleic acid (DNA) and conventional/pediatric vaccines. It is focusing its development efforts on needle free devices in the area of liquid jet delivery through the InsuJet platform. The Company's InsuJet technology platform is based on jet-stream administration of liquid drugs. The Company manufactures and commercializes needle-free injection systems and sells in over 40 countries globally.
Directors
- Last Annual
- December 31st, 2022
- Last Interim
- September 30th, 2023
- Incorporated
- March 1st, 2022
- Public Since
- May 28th, 2019
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 213,425,682
- Address
- 18 King Street East, Suite 1400, Toronto, M5C 1C4
- Web
- https://www.nugenmd.com/
- Phone
- +1 6475013290
- Auditors
- KPMG LLP
Upcoming Events for NGMD
Q1 2024 NuGen Medical Devices Inc Earnings Release
NuGen Medical Devices Inc Annual Shareholders Meeting
Q2 2024 NuGen Medical Devices Inc Earnings Release
Similar to NGMD
Aurora Spine
TSX Venture Exchange
CardioComm Solutions
TSX Venture Exchange
Cloud DX
TSX Venture Exchange
Enablence Technologies
TSX Venture Exchange
EvokAI Creative Labs
TSX Venture Exchange
FAQ
What is the NuGen Medical Devices share price?
As of Today at 19:15 UTC, shares in NuGen Medical Devices are trading at CA$0.11. This share price information is delayed by 15 minutes.
How has the NuGen Medical Devices share price performed this year?
Shares in NuGen Medical Devices last closed at CA$0.11 and the price had moved by -47.5% over the past 365 days. In terms of relative price strength the NuGen Medical Devices share price has underperformed the Toronto Stock Exchange 300 Composite Index by -50.5% over the past year.
What are the analyst and broker recommendations for NuGen Medical Devices?
There is no consensus recommendation for this security.
What is the NuGen Medical Devices dividend yield?
NuGen Medical Devices does not currently pay a dividend.
Does NuGen Medical Devices pay a dividend?
NuGen Medical Devices does not currently pay a dividend.
When does NuGen Medical Devices next pay dividends?
NuGen Medical Devices does not currently pay a dividend.
How do I buy NuGen Medical Devices shares?
To buy shares in NuGen Medical Devices you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of NuGen Medical Devices?
As of the previous close price of CA$0.11, shares in NuGen Medical Devices had a market capitalisation of CA$22.41m.
Where are NuGen Medical Devices shares listed?
Here are the trading details for NuGen Medical Devices:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: NGMD
What kind of share is NuGen Medical Devices?
Based on an overall assessment of its quality, value and momentum NuGen Medical Devices is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a NuGen Medical Devices share price forecast for 2024?
We could not find analyst target price data for this security.
What is the trend in the NuGen Medical Devices share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like NuGen Medical Devices. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -9.53%.
As of the last closing price of CA$0.11, shares in NuGen Medical Devices were trading -16.64% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the NuGen Medical Devices PE Ratio?
The NuGen Medical Devices PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.11.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of NuGen Medical Devices?
We do not have data on NuGen Medical Devices' directors